[go: up one dir, main page]

AU1454199A - Pdgf-mediated microvascular communication and methods of use thereof - Google Patents

Pdgf-mediated microvascular communication and methods of use thereof

Info

Publication number
AU1454199A
AU1454199A AU14541/99A AU1454199A AU1454199A AU 1454199 A AU1454199 A AU 1454199A AU 14541/99 A AU14541/99 A AU 14541/99A AU 1454199 A AU1454199 A AU 1454199A AU 1454199 A AU1454199 A AU 1454199A
Authority
AU
Australia
Prior art keywords
pdgf
methods
communication
mediated microvascular
mediated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU14541/99A
Other languages
English (en)
Inventor
William C. Aird
Jay M Edelberg
Robert D. Rosenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Massachusetts Institute of Technology
Original Assignee
Massachusetts Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Institute of Technology filed Critical Massachusetts Institute of Technology
Publication of AU1454199A publication Critical patent/AU1454199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU14541/99A 1997-11-07 1998-11-06 Pdgf-mediated microvascular communication and methods of use thereof Abandoned AU1454199A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6495197P 1997-11-07 1997-11-07
US60064951 1997-11-07
PCT/US1998/023892 WO1999024059A1 (fr) 1997-11-07 1998-11-06 Communication microvasculaire a mediation de pdgf et procedes d'utilisation

Publications (1)

Publication Number Publication Date
AU1454199A true AU1454199A (en) 1999-05-31

Family

ID=22059333

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14541/99A Abandoned AU1454199A (en) 1997-11-07 1998-11-06 Pdgf-mediated microvascular communication and methods of use thereof

Country Status (2)

Country Link
AU (1) AU1454199A (fr)
WO (1) WO1999024059A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020055101A1 (en) 1995-09-11 2002-05-09 Michel G. Bergeron Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
US20100267012A1 (en) 1997-11-04 2010-10-21 Bergeron Michel G Highly conserved genes and their use to generate probes and primers for detection of microorganisms
US20030049636A1 (en) 1999-05-03 2003-03-13 Bergeron Michel G. Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories
CA2937907C (fr) 1999-09-28 2017-08-22 Geneohm Sciences Canada Inc. Acides nucleiques, methodes et trousses de detection de campylobacter
WO2003025019A1 (fr) * 2001-09-20 2003-03-27 Alexion Pharmaceuticals, Inc. Anticorps anti-pdgf et procedes de production d'anticorps mis au point

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3900770A1 (de) * 1989-01-12 1990-07-26 Juergen Prof Dr Hoppe Verfahren zur herstellung von pdgf-a und pdgf-aa
DE69413009T2 (de) * 1993-02-25 1999-03-25 University of Washington, Seattle, Wash. Verwendung von antikörpern gegen pdgf-rezeptoren zur inhibierung von hyperplasie der intima

Also Published As

Publication number Publication date
WO1999024059A1 (fr) 1999-05-20

Similar Documents

Publication Publication Date Title
AU8169498A (en) Backpack assembly and method of use
AU7710198A (en) Single pass lead and method of use
AU4597297A (en) Trans-sodium crocetinate, methods of making and methods of use thereof
AU8140898A (en) Inhibitors of beta-lactamases and uses therefor
AU8849098A (en) Baculovirus artificial chromosomes and methods of use
AU1616499A (en) Chemokine variants and methods of use
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU7718898A (en) Txu-7-pap immunotoxin and use thereof
AU6028598A (en) Non-iron metalloporphyrins and methods of use
AU4890997A (en) Rayleigh-breakup atomizing devices and methods of making rayleigh-breakup atomizing devices
AU9781998A (en) Huchordin and uses thereof
AU4479997A (en) Sustained delivery device and methods of making and using the same
AU7144196A (en) Strato state platform and its use in communication
AU8662198A (en) Activated forms of notch and methods based thereon
AU9374298A (en) Preparation and use of biofilm-degrading, multiple-specificit y, hydrolytic enzyme mixtures
AU7290898A (en) Preparation of fagopyritols and uses therefor
AU5923998A (en) 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same
AU7378498A (en) Hybrid ribozymes and methods of use
AU9569998A (en) Photo-spectrometers, methods of use and manufacture
AU3118297A (en) Sok-1 and methods of use
HUP9800146A3 (en) Thalidomide-derivatives and use of them
AU2003204844A1 (en) Use of methylnaltrexone and related compounds
AU1454199A (en) Pdgf-mediated microvascular communication and methods of use thereof
AU1295099A (en) Water repellent restorative and process of use
AU3116697A (en) Human interleukin-1j and antagonists thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase